30 years of CIK cell therapy: recapitulating the key breakthroughs and future perspective

Journal of Experimental & Clinical Cancer Research

Ingo G. H. Schmidt-Wolf¹  Amit Sharma² 

[1] Department of Integrated Oncology, Center for Integrated Oncology (CIO), University Hospital Bonn, 53127, Bonn, Germany;Department of Integrated Oncology, Center for Integrated Oncology (CIO), University Hospital Bonn, 53127, Bonn, Germany;Department of Neurosurgery, University Hospital Bonn, 53127, Bonn, Germany;

关键词: Cytokine-induced killer (CIK) cell therapy;    Immunotherapies;   

DOI  :  10.1186/s13046-021-02184-2

来源: Springer

【 摘 要 】

Emerging evidence from the numerous clinical trials involving cytokine-induced killer (CIK) cell therapy suggests that its optimization in combination with other contemporary cancer therapies in a complementary manner (rather than as competition) will be a key to combat cancer.

【 授权许可】

CC BY